Want to see PVLA full AI Analyst Report?
Palvella Therapeutics (PVLA) Income Statement
Palvella Therapeutics Income Statement
Last quarter (Q2 2026), Palvella Therapeutics's total revenue was $0.00. In Q2, Palvella Therapeutics's net income was $-21.87M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 25.90M | $ 31.42M | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 23.12M | $ 29.05M | |
| $ 38.60M | $ 14.10M | $ 11.87M | $ 66.60M | $ 80.88M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 2.78M | $ 2.37M |
| $ -35.90M | $ -13.12M | $ 18.69M | $ -30.50M | $ -43.37M | |
| $ -38.60M | $ -14.10M | $ -11.87M | $ -43.47M | $ -51.83M | |
| $ -3.11M | $ -3.34M | $ 30.56M | $ 10.20M | $ 6.09M | |
| $ -41.72M | $ -17.43M | $ 18.69M | $ -33.28M | $ -45.74M | |
| $ -41.72M | $ -17.43M | $ 18.69M | $ -33.28M | $ -45.74M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.71 | $ -7.83 | $ 14.74 | $ -29.61 | $ -56.69 |
| Diluted EPS | $ -3.71 | $ -7.83 | $ 14.74 | $ -29.61 | $ -56.69 |
| Weighted Average Shares Outstanding | 11.25M | 2.23M | 1.27M | 930.35K | 806.84K |
| Weighted Average Shares Outstanding (Diluted) | 11.25M | 2.23M | 1.27M | 930.35K | 806.84K |
Currency in USD